Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Inflammatory Bowel Diseases

Free Subscription 05.08.2019 2 Aliment Pharmacol Ther 1 Am J Gastroenterol 1 Clin Gastroenterol Hepatol 2 Dig Dis Sci 1 Gastroenterol Hepatol 3 Gastroenterology 2 Gut 5 Inflamm Bowel Dis 2 J Clin Gastroenterol 2 J Crohns Colitis 3 PLoS One 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. CARMODY JK, Plevinsky J, Peugh JL, Denson LA, et al
   Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis.
   Aliment Pharmacol Ther. 2019 Aug 2. doi: 10.1111/apt.15445.
   PubMed     Text format     Abstract available
   
   
2. KREIJNE JE, de Veer RC, de Boer NK, Dijkstra G, et al
   Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment.
   Aliment Pharmacol Ther. 2019;50:407-415.
   PubMed     Text format     Abstract available
   
   

   
   Am J Gastroenterol

3. LIAO KF, Lai SW
   Association Between Inflammatory Bowel Disease and Hip Fracture.
   Am J Gastroenterol. 2019 Jul 31. doi: 10.14309/ajg.0000000000000344.
   PubMed     Text format    
   
   

   
   Clin Gastroenterol Hepatol

4. REINISCH W, Gottlieb K, Colombel JF, Danese S, et al
   Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
   Clin Gastroenterol Hepatol. 2019;17:1673-1679.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

5. BURKE KE, Nayor J, Campbell EJ, Ananthakrishnan AN, et al
   Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence.
   Dig Dis Sci. 2019 Aug 1. pii: 10.1007/s10620-019-05754.
   PubMed     Text format     Abstract available
   
   
6. ABDALLA M, Norblad R, Olsson M, Landerholm K, et al
   Anorectal Function After Ileo-Rectal Anastomosis Is Better than Pelvic Pouch in Selected Ulcerative Colitis Patients.
   Dig Dis Sci. 2019 Aug 1. pii: 10.1007/s10620-019-05757.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterol Hepatol

7. HERNANZ N, Sierra M, Volpato N, Nunez-Gomez L, et al
   Autologous haematopoietic stem cell transplantation in refractory Crohn's disease: Experience in our centre.
   Gastroenterol Hepatol. 2019;42:16-22.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

8. KELLERMAYER R
   Roseburia ssp.: Prime Candidates for Microbial Therapeutics in Inflammatory Bowel Disease.
   Gastroenterology. 2019 Jul 26. pii: S0016-5085(19)41122.
   PubMed     Text format    
   
   
9. ALBENBERG L, Brensinger CM, Wu Q, Gilroy E, et al
   A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn's Disease Flares.
   Gastroenterology. 2019;157:128-136.
   PubMed     Text format     Abstract available
   
   
10. JASWANI TS, Hobson EM, Grider DJ
    A Complication of Crohn's Disease?
    Gastroenterology. 2019;157:31-33.
    PubMed     Text format    
    
    

    
    Gut

11. TITO RY, Chaffron S, Caenepeel C, Lima-Mendez G, et al
    Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiota.
    Gut. 2019;68:1180-1189.
    PubMed     Text format     Abstract available
    
    
12. WALDSCHMITT N, Kitamoto S, Secher T, Zacharioudaki V, et al
    The regenerating family member 3 beta instigates IL-17A-mediated neutrophil recruitment downstream of NOD1/2 signalling for controlling colonisation resistance independently of microbiota community structure.
    Gut. 2019;68:1190-1199.
    PubMed     Text format     Abstract available
    
    

    
    Inflamm Bowel Dis

13. LIGHTNER AL
    Should Surgical Inflammatory Bowel Disease Patients Be Given Extended Venous Thromboembolic Prophylaxis Postoperatively?
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542811. doi: 10.1093.
    PubMed     Text format    
    
    
14. KAYAL M, Radcliffe M, Plietz M, Rosman A, et al
    Portomesenteric Venous Thrombosis in Patients Undergoing Surgery for Medically Refractory Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542812. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
15. LISKA D, Bora Cengiz T, Novello M, Aiello A, et al
    Do Patients With Inflammatory Bowel Disease Benefit from an Enhanced Recovery Pathway?
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542814. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
16. DREESEN E, Kantasiripitak W, Detrez I, Stefanovic S, et al
    A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis.
    Inflamm Bowel Dis. 2019 Aug 2. pii: 5542810. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
17. LEGA S, Pin A, Arrigo S, Cifaldi C, et al
    Diagnostic Approach to Monogenic Inflammatory Bowel Disease in Clinical Practice: A Ten-Year Multicentric Experience.
    Inflamm Bowel Dis. 2019 Aug 3. pii: 5543289. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Gastroenterol

18. ANTONELLI E, Torti G, Bassotti G
    Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative Colitis.
    J Clin Gastroenterol. 2019 Aug 1. doi: 10.1097/MCG.0000000000001250.
    PubMed     Text format     Abstract available
    
    
19. AHAMED Z R, Dutta U, Sharma V, Prasad KK, et al
    Oral Nano Vitamin D Supplementation Reduces Disease Activity in Ulcerative Colitis: A Double-Blind Randomized Parallel Group Placebo-controlled Trial.
    J Clin Gastroenterol. 2019 Jul 26. doi: 10.1097/MCG.0000000000001233.
    PubMed     Text format     Abstract available
    
    

    
    J Crohns Colitis

20. NICOLAIDES S, Vasudevan A, Van Langenberg D
    Inflammatory Bowel Disease Helpline Reduces Subsequent Inpatient Admission Rates.
    J Crohns Colitis. 2019 Aug 2. pii: 5543172. doi: 10.1093.
    PubMed     Text format    
    
    
21. ORTIZ-MASIA D, Salvador P, Macias-Ceja DC, Gisbert-Ferrandiz L, et al
    WNT2b activates epithelial-mesenchymal transition through FZD4: relevance in penetrating Crohn s disease.
    J Crohns Colitis. 2019 Jul 30. pii: 5540685. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

22. RUIZ HH, Becker S, Bai Y, Cortes-Burgos LA, et al
    Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model.
    PLoS One. 2019;14:e0220156.
    PubMed     Text format     Abstract available
    
    
23. WITTNER M, Schlicker V, Libera J, Bockmann JH, et al
    Comparison of the integrin alpha4beta7 expression pattern of memory T cell subsets in HIV infection and ulcerative colitis.
    PLoS One. 2019;14:e0220008.
    PubMed     Text format     Abstract available
    
    
24. SOONTARARAK S, Chow L, Johnson V, Coy J, et al
    Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease.
    PLoS One. 2019;14:e0220522.
    PubMed     Text format     Abstract available
    
    

    
    Scand J Gastroenterol

25. OH SJ, Lee CK, Kim YW, Jeong SJ, et al
    True cytomegalovirus colitis is a poor prognostic indicator in patients with ulcerative colitis flares: the 10-year experience of an academic referral inflammatory bowel disease center.
    Scand J Gastroenterol. 2019 Jul 29:1-8. doi: 10.1080/00365521.2019.1646798.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: